Founder & Principal Consultant
Lima Hui BioConsulting
Chia-Yung Wu, Ph.D., DASM, has extensive research experience in T cell immunology and engineering, specializing in preclinical development of next-generation CAR-T, TCR-T, and T cell engagers. Currently, Dr. Wu is the Founder and Principal Consultant of Lima Hui BioConsulting, supporting biotech leaders with preclinical development of T cell-based immunotherapies. Her prior positions in the biotech/pharma industry include R&D group leader and project team leader roles at Amgen, CERo Therapeutics, Bristol Myers Squibb, and Affini-T Therapeutics. Dr. Wu completed a B.S. in Biochemistry at Rutgers University—New Brunswick, a Ph.D. in Cell Biology at Massachusetts Institute of Technology, and a postdoctoral fellowship in Synthetic Biology at University of California, San Francisco. Besides her scientific credentials, Dr. Wu is certified as a Disciplined Agile Scrum Master by the Project Management Institute.
Cell and Gene Therapy: Transforming Treatment Paradigms for Patient-Centric Care
Friday, April 4, 2025
10:00 AM - 2:00 PM East Coast USA Time